Frost & Sullivan Independent Equity Research
DNA Biomedical Solutions Ltd.: The company and its holdings can become a major force in the osteoporosis care market, pending success in next year’s clinical trials.
![dnaLogo dnaLogo](https://www.frostequityresearch.com/wp-content/uploads/elementor/thumbs/dnaLogo-nx7oepmjwr0nqu046yc3t5fs9jyo1sg30b9j97epgk.png)
Company: DNA Biomedical Solutions Ltd.
Sector: Healthcare
Report type: Initiation of Coverage
Published on: October 9 , 2017